CN111280449B - 一种肠内缓释糖醇添加剂及其制备方法和应用 - Google Patents
一种肠内缓释糖醇添加剂及其制备方法和应用 Download PDFInfo
- Publication number
- CN111280449B CN111280449B CN202010087312.6A CN202010087312A CN111280449B CN 111280449 B CN111280449 B CN 111280449B CN 202010087312 A CN202010087312 A CN 202010087312A CN 111280449 B CN111280449 B CN 111280449B
- Authority
- CN
- China
- Prior art keywords
- sugar alcohol
- solution
- fermented
- alcohol additive
- xylitol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000654 additive Substances 0.000 title claims abstract description 49
- 230000000996 additive effect Effects 0.000 title claims abstract description 49
- 150000005846 sugar alcohols Chemical class 0.000 title claims abstract description 49
- 230000000968 intestinal effect Effects 0.000 title claims abstract description 36
- 238000002360 preparation method Methods 0.000 title claims description 11
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims abstract description 37
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims abstract description 35
- 239000000811 xylitol Substances 0.000 claims abstract description 35
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims abstract description 35
- 229960002675 xylitol Drugs 0.000 claims abstract description 35
- 235000010447 xylitol Nutrition 0.000 claims abstract description 35
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims abstract description 24
- 238000013268 sustained release Methods 0.000 claims abstract description 21
- 239000012730 sustained-release form Substances 0.000 claims abstract description 21
- 241000186000 Bifidobacterium Species 0.000 claims abstract description 20
- 229920001817 Agar Polymers 0.000 claims abstract description 19
- 239000008272 agar Substances 0.000 claims abstract description 19
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 claims abstract description 17
- 229930003779 Vitamin B12 Natural products 0.000 claims abstract description 17
- 239000011715 vitamin B12 Substances 0.000 claims abstract description 17
- 235000019163 vitamin B12 Nutrition 0.000 claims abstract description 17
- 239000000679 carrageenan Substances 0.000 claims abstract description 16
- 235000010418 carrageenan Nutrition 0.000 claims abstract description 16
- 229920001525 carrageenan Polymers 0.000 claims abstract description 16
- 229940113118 carrageenan Drugs 0.000 claims abstract description 16
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims abstract description 16
- 229920002148 Gellan gum Polymers 0.000 claims abstract description 12
- 229920002907 Guar gum Polymers 0.000 claims abstract description 12
- 241000186660 Lactobacillus Species 0.000 claims abstract description 12
- 239000000216 gellan gum Substances 0.000 claims abstract description 12
- 235000010492 gellan gum Nutrition 0.000 claims abstract description 12
- 239000000665 guar gum Substances 0.000 claims abstract description 12
- 235000010417 guar gum Nutrition 0.000 claims abstract description 12
- 229960002154 guar gum Drugs 0.000 claims abstract description 12
- 238000000034 method Methods 0.000 claims abstract description 12
- 239000000230 xanthan gum Substances 0.000 claims abstract description 12
- 229920001285 xanthan gum Polymers 0.000 claims abstract description 12
- 235000010493 xanthan gum Nutrition 0.000 claims abstract description 12
- 229940082509 xanthan gum Drugs 0.000 claims abstract description 12
- 241000186429 Propionibacterium Species 0.000 claims abstract description 9
- 229940039696 lactobacillus Drugs 0.000 claims abstract description 9
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims abstract 6
- 239000000243 solution Substances 0.000 claims description 46
- 239000008188 pellet Substances 0.000 claims description 14
- 238000002156 mixing Methods 0.000 claims description 13
- 239000000084 colloidal system Substances 0.000 claims description 10
- 239000011259 mixed solution Substances 0.000 claims description 9
- 230000001954 sterilising effect Effects 0.000 claims description 8
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims description 7
- 238000001816 cooling Methods 0.000 claims description 6
- 238000012258 culturing Methods 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 235000013305 food Nutrition 0.000 claims description 5
- 239000012153 distilled water Substances 0.000 claims description 4
- 238000004108 freeze drying Methods 0.000 claims description 3
- 238000007602 hot air drying Methods 0.000 claims description 3
- 238000005303 weighing Methods 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims 2
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical class S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 claims 1
- SRBFZHDQGSBBOR-IOVATXLUSA-N Xylose Natural products O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 claims 1
- -1 xylose alcohols Chemical class 0.000 claims 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 abstract description 24
- 235000019260 propionic acid Nutrition 0.000 abstract description 12
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 abstract description 12
- 230000015572 biosynthetic process Effects 0.000 abstract description 4
- 238000003786 synthesis reaction Methods 0.000 abstract description 4
- 244000005700 microbiome Species 0.000 abstract description 3
- 230000033228 biological regulation Effects 0.000 abstract description 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000029087 digestion Effects 0.000 description 15
- 210000001072 colon Anatomy 0.000 description 12
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 11
- 210000000813 small intestine Anatomy 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 6
- 210000001035 gastrointestinal tract Anatomy 0.000 description 6
- 230000002496 gastric effect Effects 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 239000012530 fluid Substances 0.000 description 3
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 3
- 229940107187 fructooligosaccharide Drugs 0.000 description 3
- 210000004051 gastric juice Anatomy 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 238000000227 grinding Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 238000004088 simulation Methods 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- HEBKCHPVOIAQTA-QWWZWVQMSA-N D-arabinitol Chemical compound OC[C@@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-QWWZWVQMSA-N 0.000 description 2
- ZAQJHHRNXZUBTE-WUJLRWPWSA-N D-xylulose Chemical compound OC[C@@H](O)[C@H](O)C(=O)CO ZAQJHHRNXZUBTE-WUJLRWPWSA-N 0.000 description 2
- 241001052560 Thallis Species 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 229940095674 pellet product Drugs 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 241000186016 Bifidobacterium bifidum Species 0.000 description 1
- 241000588921 Enterobacteriaceae Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 102100031416 Gastric triacylglycerol lipase Human genes 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000003833 bile salt Substances 0.000 description 1
- 229940093761 bile salts Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000000112 colonic effect Effects 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 108010091264 gastric triacylglycerol lipase Proteins 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 230000004110 gluconeogenesis Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000008621 organismal health Effects 0.000 description 1
- 210000001819 pancreatic juice Anatomy 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- SXBRULKJHUOQCD-UHFFFAOYSA-N propanoic acid Chemical compound CCC(O)=O.CCC(O)=O SXBRULKJHUOQCD-UHFFFAOYSA-N 0.000 description 1
- 150000004666 short chain fatty acids Chemical class 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
- A23L29/37—Sugar alcohols
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/238—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from seeds, e.g. locust bean gum or guar gum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/256—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from seaweeds, e.g. alginates, agar or carrageenan
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/269—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of microbial origin, e.g. xanthan or dextran
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/269—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of microbial origin, e.g. xanthan or dextran
- A23L29/272—Gellan
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P20/00—Coating of foodstuffs; Coatings therefor; Making laminated, multi-layered, stuffed or hollow foodstuffs
- A23P20/10—Coating with edible coatings, e.g. with oils or fats
- A23P20/12—Apparatus or processes for applying powders or particles to foodstuffs, e.g. for breading; Such apparatus combined with means for pre-moistening or battering
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P20/00—Coating of foodstuffs; Coatings therefor; Making laminated, multi-layered, stuffed or hollow foodstuffs
- A23P20/10—Coating with edible coatings, e.g. with oils or fats
- A23P20/15—Apparatus or processes for coating with liquid or semi-liquid products
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Jellies, Jams, And Syrups (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- General Preparation And Processing Of Foods (AREA)
Abstract
本发明涉及一种肠内缓释糖醇添加剂包括两层结构,在其内层结构中包含有木糖醇和琼脂的组分,在其外层结构中包含有卡拉胶或结冷胶或黄原胶或瓜尔豆胶、维生素B12、L‑阿拉伯糖以及发酵的双歧杆菌或发酵的丙酸杆菌或发酵的乳杆菌的组分。本发明还公开制备肠内缓释糖醇添加剂的方法及其应用。本发明使用复配的木糖醇、L‑阿拉伯糖和维生素B12,实现了肠道微生物定向调控,并实现肠内丙酸高浓度合成。
Description
技术领域
本发明属于肠内缓释产品的制备技术领域,特别涉及一种肠内缓释糖醇添加剂及其制备方法和应用。
背景技术
丙酸被吸收后主要在肝脏中被代谢,参与糖异生,抑制胆固醇合成,但已经有各种研究表明,外源性地摄入和自体产生的丙酸作用并不一样,外来的丙酸对个体的许多代谢过程有重要影响。丙酸(propionate)是一种短链脂肪酸,正常情况下,人体中的微生物是能够在结肠中通过发酵未完全消化的碳水化合物来产生丙酸的,这些丙酸对人体是有益的。而外源性丙酸在短期内会导致高血糖、胰岛素偏高,长期摄入将会造成肥胖和胰岛素抵抗等更严重的症状。
低聚果糖、多糖具有在肠道内生成丙酸的功能。但是无论低聚果糖还是多糖都不能定点、高浓度的合成丙酸。多糖的肠内利用率不高,且容易导致胀气等问题。低聚果糖同样会导致产气过多,与产酸不稳定等问题,甚至会产生果糖过多导致肝脏代谢紊乱问题。
发明内容
本发明所要解决的技术问题在于,提供一种肠内缓释糖醇添加剂及其制备方法和应用,促进机体健康同时,消除丙酸可能产生的代谢副作用,实现糖醇添加剂在肠道内的缓慢释放和结肠内定点释放。
本发明是这样实现的,提供一种肠内缓释糖醇添加剂,其包括两层结构,在其内层结构中包含有木糖醇和琼脂的组分,在其外层结构中包含有卡拉胶或结冷胶或黄原胶或瓜尔豆胶、维生素B12、L-阿拉伯糖以及发酵的双歧杆菌或发酵的丙酸杆菌或发酵的乳杆菌的组分。
本发明是这样实现的,还提供一种如前所述的肠内缓释糖醇添加剂的制备方法,包括以下步骤:
步骤一、将木糖醇与琼脂混合,灭菌,放入球型磨具静置冷却制成木糖醇琼脂小球;
步骤二、配制卡拉胶溶液或结冷胶溶液或黄原胶溶液或瓜尔豆胶溶液,将维生素B12、L-阿拉伯糖加入到卡拉胶溶液或结冷胶溶液或黄原胶溶液或瓜尔豆胶溶液中混匀得到混合液,再将该混合液包裹步骤一的木糖醇琼脂小球,得到包裹混合液的木糖醇琼脂的二层胶体小球;
步骤三、将步骤二制备的二层胶体小球放置于发酵的双歧杆菌培养液或发酵的丙酸杆菌培养液或发酵的乳杆菌培养液中培养,培养后取出再进行冷冻或热风干燥,得到糖醇添加剂成品。
本发明是这样实现的,还提供一种如前所述的肠内缓释糖醇添加剂的应用,所述糖醇添加剂应用于食品上。
本发明是这样实现的,还提供一种如前所述的肠内缓释糖醇添加剂的制备方法制备的肠内缓释糖醇添加剂的应用,所述糖醇添加剂应用于食品上。
与现有技术相比,本发明的肠内缓释糖醇添加剂及其制备方法和应用具有以下特点:
1. 使用木糖醇、L-阿拉伯糖和维生素B12,实现了肠道微生物定向调控,并实现肠内丙酸高浓度合成;
2. 使用分层包埋技术,实现了肠道内的糖醇缓释和分层释放;
3. 本方法的小球技术,实现了双歧杆菌类或丙酸杆菌类或乳杆菌类产品稳定性。
附图说明
图1为本发明的肠内缓释糖醇添加剂中的木糖醇组分在模拟胃、小肠和结肠消化过程中含量变化示意图;
图2为本发明的肠内缓释糖醇添加剂中的阿拉伯糖组分在模拟胃、小肠和结肠消化过程中含量变化示意图;
图3为本发明的二层胶体小球产品与肠内缓释糖醇添加剂成品在模拟结肠实验中双歧杆菌属的相对丰度对比示意图。
具体实施方式
为了使本发明所要解决的技术问题、技术方案及有益效果更加清楚明白,以下结合附图及实施例,对本发明进行进一步详细说明。应当理解,此处所描述的具体实施例仅仅用以解释本发明,并不用于限定本发明。
本发明的肠内缓释糖醇添加剂包括两层结构,在其内层结构中包含有木糖醇和琼脂的组分,在其外层结构中包含有卡拉胶或结冷胶或黄原胶或瓜尔豆胶、维生素B12、L-阿拉伯糖以及发酵的双歧杆菌或发酵的丙酸杆菌或发酵的乳杆菌的组分。
具体地,在所述糖醇添加剂中,所含的木糖醇、L-阿拉伯糖、维生素B12的组分比为1~33:1:0.005。
本发明的肠内缓释糖醇添加剂通过木糖醇、L-阿拉伯糖和维生素B12复配,L-阿拉伯糖减缓木酮糖向阿拉伯糖醇代谢并控制代谢流,维生素B12增加丙酸代谢途径,实现了首先诱导肠杆菌科和毛罗菌科菌与木糖醇相关的基因表达增加,从而增加木糖醇向PPPpathway途径代谢,减弱木酮糖代谢为阿拉伯糖醇途径,增加丙酸合成数量。
本发明的肠内缓释糖醇添加剂采用两层结构,以木糖醇为核心,用卡拉胶等食用胶制备L-阿拉伯糖和维生素B12的二层胶体,实现木糖醇和L-阿拉伯糖在肠道内的缓慢释放和结肠内定点释放。
本发明还公开一种如前所述的肠内缓释糖醇添加剂的制备方法,包括以下步骤:
步骤一、将木糖醇与琼脂混合,灭菌,放入球型磨具静置冷却制成木糖醇琼脂小球。
步骤二、配制卡拉胶溶液或结冷胶溶液或黄原胶溶液或瓜尔豆胶溶液,将维生素B12、L-阿拉伯糖加入到卡拉胶溶液或结冷胶溶液或黄原胶溶液或瓜尔豆胶溶液中混匀得到混合液,再将该混合液包裹步骤一的木糖醇琼脂小球,得到包裹混合液的木糖醇琼脂的二层胶体小球。
步骤三、将步骤二制备的二层胶体小球放置于发酵的双歧杆菌培养液或发酵的丙酸杆菌培养液或发酵的乳杆菌培养液中培养,培养后取出再进行冷冻或热风干燥,得到糖醇添加剂成品。
下面结合具体实施例进一步说明本发明的肠内缓释糖醇添加剂的制备方法。
实施例1
本发明的第一种肠内缓释糖醇添加剂的制备方法的实施例,包括以下步骤:
步骤一、称取一定量的木糖醇与2%的琼脂混合,121℃灭菌15min,待冷却至55℃时,用一次性无菌胶头滴管吸取转移到球型磨具中,静置冷却即可制成木糖醇琼脂小球。
步骤二、称取2g卡拉胶,溶解于100mL蒸馏水中,121℃灭菌15min,待冷却至50℃~60℃,温度不高于60℃,便于维生素B12稳定,避光,无菌L-阿拉伯糖、维生素B12按照混合配方比1:0.005加入到卡拉胶溶液中混匀,在无菌超净台中包裹到木糖醇琼脂小球制成配方比为1~33:1:0.005的二层胶体小球。
步骤三、将步骤二制备的二层胶体小球按照总体积的1:3添加入双歧杆菌发酵(109CFU/mL)液中,静止培养24小时;培养后取出带菌小球再进行冷冻干燥1h~24h或热风干燥30min,得到糖醇添加剂成品。
在上述实施例中,如果将双歧杆菌替换为丙酸杆菌或乳杆菌以得到新的实施例。
选取本实施例制备的肠内缓释糖醇添加剂进行胃消化、小肠消化和结肠消化模拟实验进行验证。实验方法如下:
1)模拟胃液准备:将0.62g的NaCl、0.22g的KCl、0.05g的CaCl2、0.12g的NaHCO3溶于200mL蒸馏水中,使用0.1M的HCl溶液调节pH至2.0,制得胃液培养基。然后,将1.0mL的CH3COONa(1.0mol/L,pH5)、23.6g胃蛋白酶和25.0g胃脂肪酶分别加入100mL胃培养基中,然后将培养基的pH值用0.1M的HCl溶液调整到2.0。
2)模拟胃液消化:按照木糖醇1%~5%的剂量,将实施例1的糖醇添加剂成品小球与模拟胃液体积1:1混合,37℃水浴0.5h、1h、2h、4h、6h,分别取出消化后的样品。
3)模拟小肠消化液制备:将0.54g的NaCl、0.065g的KCl、0.033g的CaCl2溶于100mL蒸馏水中,用0.1M的NaOH溶液调节pH至7.0,制备小肠培养基。在小肠培养基中分别加入6.5mg胰蛋白酶、200.0g胆盐(4%,w/w)和50.0g胰酶液(7%,w/w)。用0.1M的NaOH溶液,室温连续搅拌,调节溶液pH至7.5,模拟小肠消化液。
4)模拟小肠消化:将模拟胃液消化后的样品分别与小肠液体积比3:7混合,37℃水浴0.5h、1h、2h、4h、6h,分别取出消化后的样品。
5)将实施例1的二层胶体小球样品(无包埋双歧杆菌菌体)和糖醇添加剂成品小球样品(有包埋双歧杆菌菌体)按照木糖醇1%~5%剂量,补充到CDMN(Chang Dao Mo Ni)结肠体外模拟系统,收集模拟结肠消化24h、48h的小球样品。
6)使用HPLC分别测定模拟胃消化、模拟小肠消化、模拟结肠消化后保留在小球中的木糖醇、阿拉伯糖的含量,以及双歧杆菌属的丰度值,得到如图1至图3所示的对比曲线。
如图1和图2所示,以木糖醇:阿拉伯糖=25:1的小球为例,每个小球中木糖醇含量为1g,阿拉伯糖含量为0.04g。前6小时为胃消化、6~12小时为小肠消化、12~60小时为大肠微生物消化后小球中木糖醇和阿拉伯糖含量。说明本发明的小球对阿拉伯糖和木糖醇能够起缓慢、定点释放的效果。
如图3所示,本发明的小球内双歧杆菌包埋(糖醇添加剂成品)相比于不包埋(二层胶体小球产品),能够显著促进小球中双歧杆菌的相对丰度,从而促进结肠中双歧杆菌相对丰度。
因此,本发明的肠内缓释糖醇添加剂使用分层包埋技术,实现了肠道内的糖醇缓释和分层释放,而且,促进结肠中双歧杆菌的相对丰度。
本发明还公开一种如前所述的肠内缓释糖醇添加剂的应用,所述糖醇添加剂应用于食品上。
本发明还公开一种如前所述的肠内缓释糖醇添加剂的制备方法制备的肠内缓释糖醇添加剂的应用,所述糖醇添加剂应用于食品上。
例如本发明的肠内缓释糖醇添加剂被应用在饮料、糕点中,促进人体结肠内的丙酸的产生,调节肠道健康。
Claims (5)
1.一种肠内缓释糖醇添加剂的制备方法,其特征在于,肠内缓释糖醇添加剂包括两层结构,其内层结构为:木糖醇和琼脂;其外层结构为:卡拉胶或结冷胶或黄原胶或瓜尔豆胶中任意一种,维生素B12,L-阿拉伯糖以及发酵的双歧杆菌或发酵的丙酸杆菌或发酵的乳杆菌;在所述糖醇添加剂中,所含的木糖醇、L-阿拉伯糖、维生素B12的组分比为1~33:1:0.005,所述制备方法包括以下步骤:
步骤一、将木糖醇与琼脂混合,灭菌,放入球型模具静置冷却制成木糖醇琼脂小球,琼脂的浓度为2%;
步骤二、配制卡拉胶溶液或结冷胶溶液或黄原胶溶液或瓜尔豆胶溶液,将维生素B12、L-阿拉伯糖加入到卡拉胶溶液或结冷胶溶液或黄原胶溶液或瓜尔豆胶溶液中混匀得到混合液,再将该混合液包裹步骤一的木糖醇琼脂小球,得到包裹混合液的木糖醇琼脂的二层胶体小球;
步骤三、将步骤二制备的二层胶体小球放置于发酵的双歧杆菌培养液或发酵的丙酸杆菌培养液或发酵的乳杆菌培养液中培养,培养后取出再进行冷冻干燥或热风干燥,得到糖醇添加剂成品。
2.如权利要求1所述的肠内缓释糖醇添加剂的制备方法,其特征在于,在步骤一中,灭菌条件是121℃灭菌15min。
3.如权利要求1所述的肠内缓释糖醇添加剂的制备方法,其特征在于,在步骤二中,配制卡拉胶溶液或结冷胶溶液或黄原胶溶液或瓜尔豆胶溶液的方法包括:称取2g卡拉胶或结冷胶或黄原胶或瓜尔豆胶,溶解于100mL蒸馏水中,121℃灭菌15min,待冷却至温度50℃~60℃。
4.如权利要求1所述的肠内缓释糖醇添加剂的制备方法,其特征在于,在步骤三中,在发酵的双歧杆菌培养液或发酵的丙酸杆菌培养液或发酵的乳杆菌培养液中双歧杆菌或丙酸杆菌或乳杆菌浓度为109CFU/mL,二层胶体小球放置于发酵的双歧杆菌培养液或发酵的丙酸杆菌培养液或发酵的乳杆菌培养液中培养24h,冷冻干燥或热风干燥的条件是冷冻干燥1h~24h或热风干燥30min。
5.一种如权利要求1至4中任意一项所述的肠内缓释糖醇添加剂的制备方法制备的肠内缓释糖醇添加剂的应用,其特征在于,所述糖醇添加剂应用于食品上。
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010087312.6A CN111280449B (zh) | 2020-02-11 | 2020-02-11 | 一种肠内缓释糖醇添加剂及其制备方法和应用 |
US17/775,193 US20220395009A1 (en) | 2020-02-11 | 2021-02-07 | Enteral sustained-release sugar alcohol additive, preparation method therefor and application thereof |
EP21753804.0A EP4023077B1 (en) | 2020-02-11 | 2021-02-07 | Enteral sustained-release sugar alcohol additive, preparation method therefor and application thereof |
PCT/CN2021/075696 WO2021160054A1 (zh) | 2020-02-11 | 2021-02-07 | 一种肠内缓释糖醇添加剂及其制备方法和应用 |
JP2022523974A JP7368618B2 (ja) | 2020-02-11 | 2021-02-07 | 腸内徐放性糖アルコール添加剤及びその製造方法並びに応用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010087312.6A CN111280449B (zh) | 2020-02-11 | 2020-02-11 | 一种肠内缓释糖醇添加剂及其制备方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111280449A CN111280449A (zh) | 2020-06-16 |
CN111280449B true CN111280449B (zh) | 2022-11-11 |
Family
ID=71017984
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010087312.6A Active CN111280449B (zh) | 2020-02-11 | 2020-02-11 | 一种肠内缓释糖醇添加剂及其制备方法和应用 |
Country Status (5)
Country | Link |
---|---|
US (1) | US20220395009A1 (zh) |
EP (1) | EP4023077B1 (zh) |
JP (1) | JP7368618B2 (zh) |
CN (1) | CN111280449B (zh) |
WO (1) | WO2021160054A1 (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111280449B (zh) * | 2020-02-11 | 2022-11-11 | 浙江华康药业股份有限公司 | 一种肠内缓释糖醇添加剂及其制备方法和应用 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2436514A (en) * | 2006-03-28 | 2007-10-03 | Tate & Lyle Plc | A granulated sugar product |
US9084434B2 (en) * | 2006-09-27 | 2015-07-21 | Little Calumet Holdings Llc | Probiotic oral dosage forms |
DK2925300T6 (da) * | 2012-11-29 | 2021-02-08 | Progel Pty Ltd | Mikropartikler omfattende et probiotikum, et reagens, der kan tværbindes, et denatureret protein, et polyolplastificeringsmiddel og trehalose |
ES2620057T3 (es) * | 2013-01-21 | 2017-06-27 | ETH Zürich | Composición de alimento infantil que comprende bacterias viables productoras de ácido propiónico y bacterias viables productoras de ácido láctico |
EP3285785B1 (en) * | 2015-04-23 | 2024-02-21 | Compagnie Gervais Danone | Composition for reducing intestinal gas production |
WO2016205172A1 (en) * | 2015-06-15 | 2016-12-22 | Banner Life Sciences Llc | Soft lozenges comprising corticosteroids |
US10548844B2 (en) * | 2015-12-14 | 2020-02-04 | Massachusetts Institute Of Technology | pH-responsive mucoadhesive polymeric encapsulated microorganisms |
CN105595359A (zh) * | 2016-01-29 | 2016-05-25 | 江苏微康生物科技有限公司 | 一种定位缓释微囊益生菌及其制备方法 |
CN106820069A (zh) * | 2016-12-28 | 2017-06-13 | 山东龙力生物科技股份有限公司 | 一种具有调节肠道功能的天然复配甜味剂及其制备方法 |
CN107259577A (zh) * | 2017-07-25 | 2017-10-20 | 李立风 | 益生菌凝胶粒及其制备方法 |
CN108576895B (zh) * | 2018-03-06 | 2021-04-30 | 特素生物科技(天津)有限公司 | 缓释营养主食及其制备方法 |
WO2019209261A1 (en) * | 2018-04-24 | 2019-10-31 | Novus International Inc. | Protected compositions comprising two coating layers |
CN109528683A (zh) * | 2018-12-13 | 2019-03-29 | 浙江华康药业股份有限公司 | 一种阿拉伯糖定点释放对肠内产丁酸菌的调控方法 |
CN109364096A (zh) * | 2018-12-25 | 2019-02-22 | 浙江华康药业股份有限公司 | 一种木糖醇肠溶片及其制备方法和应用 |
CN110584119A (zh) * | 2019-10-09 | 2019-12-20 | 浙江华康药业股份有限公司 | 一种低糖的益生组合物及其制备方法和应用 |
CN111280449B (zh) * | 2020-02-11 | 2022-11-11 | 浙江华康药业股份有限公司 | 一种肠内缓释糖醇添加剂及其制备方法和应用 |
-
2020
- 2020-02-11 CN CN202010087312.6A patent/CN111280449B/zh active Active
-
2021
- 2021-02-07 WO PCT/CN2021/075696 patent/WO2021160054A1/zh active Application Filing
- 2021-02-07 US US17/775,193 patent/US20220395009A1/en active Pending
- 2021-02-07 EP EP21753804.0A patent/EP4023077B1/en active Active
- 2021-02-07 JP JP2022523974A patent/JP7368618B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
EP4023077B1 (en) | 2023-08-02 |
WO2021160054A1 (zh) | 2021-08-19 |
EP4023077A1 (en) | 2022-07-06 |
JP2022553097A (ja) | 2022-12-21 |
EP4023077C0 (en) | 2023-08-02 |
JP7368618B2 (ja) | 2023-10-24 |
EP4023077A4 (en) | 2022-11-23 |
US20220395009A1 (en) | 2022-12-15 |
CN111280449A (zh) | 2020-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103763940B (zh) | 促进有益微生物群生长的益生菌和人乳寡糖的合益素组合 | |
CN112041427A (zh) | 合生元组合物 | |
CN113230280B (zh) | 一种结肠靶向的益生菌多层包埋微胶囊及其制备方法与应用 | |
CN106880051B (zh) | 一种植物乳杆菌软胶囊的制备方法 | |
WO2021073197A1 (zh) | 含乳酸菌的组合物及其用途 | |
CN106974262B (zh) | 肠道益生杆菌在治疗和预防肥胖及其相关疾病中的应用 | |
CN115944665B (zh) | 一种改善肠道菌群平衡的益生菌剂及其制备方法和应用 | |
CN111280449B (zh) | 一种肠内缓释糖醇添加剂及其制备方法和应用 | |
EP3768252A1 (en) | Pharmaceutical compositions | |
Wang et al. | Prebiotic effects of resistant starch nanoparticles on growth and proliferation of the probiotic Lactiplantibacillus plantarum subsp. plantarum | |
CN106994134A (zh) | 肠道益生菌在预防和/或治疗糖尿病及其相关疾病中的应用 | |
CN106479906B (zh) | 肠道细菌丁酸杆菌(Butyribacter intestini)及其应用 | |
CN115969957A (zh) | 一种炎性肠病复合益生菌制剂及其制备方法 | |
CN215958192U (zh) | 一种具有多层保护缓释结构的益生菌珠 | |
CN113812634A (zh) | 一种合生元组合物及其制备方法与应用 | |
CN113397170B (zh) | 一种用于调节人体肠道菌群的海洋益生元组合物的应用 | |
Maekivuokko et al. | The effect of cocoa and polydextrose on bacterial fermentation in gastrointestinal tract simulations | |
WO2022248588A1 (en) | Insulin-sensitizing agent and butyrate-producing bacterium | |
CN114990017A (zh) | 一种改善胃肠功能和睡眠障碍的益生菌组合物及其制备方法和应用 | |
CN106727731A (zh) | 一种微生态健胃整肠制剂及其制备方法 | |
CN117070425B (zh) | 提高益生菌在机体内代谢稳定性的工艺方法及益生菌冻干粉 | |
CN106974940B (zh) | 厚壁菌类益生菌在治疗和预防肥胖及其相关疾病中的应用 | |
Huang et al. | Preparation and synbiotic interaction mechanism of microcapsules of Bifidobacterium animalis F1–7 and human milk oligosaccharides (HMO) | |
CN115381871B (zh) | 一种果胶低聚糖益生菌复合物软胶囊及制备方法和应用 | |
CN115399471B (zh) | 一种具有调节肠道菌群的静电纺丝微球靶向结肠体系及其制备方法与应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Cheng Xinping Inventor after: Li Mian Inventor after: Zhu Xuan Inventor after: Shi Lihua Inventor after: Ye Kun Inventor after: Xiang Shasha Inventor before: Xiang Shasha Inventor before: Zhu Xuan Inventor before: Shi Lihua Inventor before: Ye Kun Inventor before: Li Mian |
|
GR01 | Patent grant | ||
GR01 | Patent grant |